Similarly, in the same cancer, CD44 was targeted through the direct administration of ON-TARGET plus human CD44 siRNA or indirectly by silencing mucin (MUC5AC) gene expression using a small hairpin RNA construct (pSUPER-Retro-shMUC5AC). This evidence concerns the gene CD44 and cancer.